FDA nod to Johnson & Johnson’s AKEEGA for aggressive prostate cancer
Astellas & Pfizer report breakthrough Phase 3 results in muscle-invasive bladder cancer
Merck’s KEYTRUDA–Padcev combo delivers survival gains in Phase 3 bladder cancer trial
Godavari Biorefineries launches US biotech arm to advance novel cancer therapies
AstraZeneca India receives permission from CDSCO for Datopotamab Deruxtecan powder
Biocon Biologics honored as 2025 Asia IP Elite by IAM for 9th consecutive year
Vanda Pharmaceuticals seeks FDA nod for breakthrough psoriasis drug
Ascletis Pharma reports positive Phase I results for oral IL-17 inhibitor
Minghui Pharmaceutical gets FDA green light for Phase III trials of its therapy in thyroid eye disease
Gujarat Kidney and Super Speciality to file IPO at Rs.108- Rs.114 per share
Ranibizumab is a recombinant humanized IgG1 monoclonal antibody fragment that binds to and inhibits vascular endothelial growth factor A
Subscribe To Our Newsletter & Stay Updated
Chasing Consistency: Centralizing operations data is the key to optimizing chemicals plants
Implementing a digital transformation in chemical operations to maximize profitability
The complexity of compliance
The Sprint to the Summit: Unlocking Lab Efficiency through Digital Transformation
The guiding role of fluidized and spouted bed technologies in particle building processes
_Logo.png){kind=logo}
